Wikidata

(Q42481553)

English

Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer Model

scientific article published on 26 August 2015

In more languages

Statements

title
Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer Model (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
26310543
retrieved
1 November 2017
author name string
Michael D Curley
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
26310543
retrieved
1 November 2017
Lucia Wille
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
26310543
retrieved
1 November 2017
Bambang S Adiwijaya
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
26310543
retrieved
1 November 2017
Gabriela Garcia
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
26310543
retrieved
1 November 2017
Victor Moyo
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
26310543
retrieved
1 November 2017
Armina A Kazi
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
26310543
retrieved
1 November 2017
Angela Brodie
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
26310543
retrieved
1 November 2017
Gavin MacBeath
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
26310543
retrieved
1 November 2017
publication date
26 August 2015
1 reference
stated in
Europe PubMed Central
PubMed ID
26310543
retrieved
1 November 2017
page(s)
2642-2652
1 reference
stated in
Europe PubMed Central
PubMed ID
26310543
retrieved
1 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42481553&oldid=2158734480"